title: Atherosclerosis: targeting endogenous apo A-I--a new approach for raising HDL.
authors.affiliation: Division of Cardiology and Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute, Suite 5531, Cedars Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. shahp@cshs.org
authors.forename: Prediman K
authors.initials: PK
authors.lastname: Shah
mesh_terms: D016632:Apolipoprotein A-I / Q000187:drug effects / Q000378:metabolism*; D008076:Cholesterol, HDL / Q000187:drug effects / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D011799:Quinazolines / Q000627:therapeutic use*; D052999:Quinazolinones; D012307:Risk Factors
chemical_list: D016632:Apolipoprotein A-I; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D011799:Quinazolines; D052999:Quinazolinones; C000628794:apabetalone